Does RELUGOLIX Cause Product dose omission issue? 1,189 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,189 reports of Product dose omission issue have been filed in association with RELUGOLIX (Orgovyx). This represents 5.8% of all adverse event reports for RELUGOLIX.
1,189
Reports of Product dose omission issue with RELUGOLIX
5.8%
of all RELUGOLIX reports
16
Deaths
155
Hospitalizations
How Dangerous Is Product dose omission issue From RELUGOLIX?
Of the 1,189 reports, 16 (1.3%) resulted in death, 155 (13.0%) required hospitalization, and 2 (0.2%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RELUGOLIX. However, 1,189 reports have been filed with the FAERS database.
What Other Side Effects Does RELUGOLIX Cause?
Hot flush (6,845)
Fatigue (5,203)
Therapy interrupted (3,251)
Incorrect dose administered (1,917)
Asthenia (1,718)
Arthralgia (1,385)
Diarrhoea (1,383)
Dizziness (1,146)
Constipation (902)
Death (832)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which RELUGOLIX Alternatives Have Lower Product dose omission issue Risk?
RELUGOLIX vs REMDESIVIR
RELUGOLIX vs REMERON
RELUGOLIX vs REMICADE
RELUGOLIX vs REMIFENTANIL
RELUGOLIX vs REMIMAZOLAM